Exhibit 107.1
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Neumora Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Per Unit | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee(3) | |||||||||
Fees to be Paid | Equity | Common stock, $0.0001 par value per share | Rule 457(a) | 16,916,500 | $18.00(2) | $304,497,000(2) | $110.2 per $1,000,000 | $33,555.57 | ||||||||
Fees Previously Paid | Equity | Common stock, $0.0001 par value per share | Rule 457(o) | — | — | $100,000,000(3) | $110.2 per $1,000,000 | $11,020.00 | ||||||||
Total Offering Amounts | $304,497,000 | $33,555.57 | ||||||||||||||
Total Fees Previously Paid | $110.2 per $1,000,000 | $11,020.00 | ||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $22,535.57 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(a) of the Securities Act of 1933, as amended (the “Securities Act”). Includes 2,206,500 shares that the underwriters have the option to purchase. See “Underwriting.” |
(2) | Calculated pursuant to Rule 457(a) of the Securities Act, based on an estimate of the proposed maximum aggregate offering price. |
(3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act. |